Kemicetine Succinate Injection Ref.[2643] Active ingredients: Chloramphenicol

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2009  Publisher: Pharmacia Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

Pharmacodynamic properties

After administration chloramphenicol is rapidly released from chloramphenicol sodium succinate. Chloramphenicol is active against many gram-positive and gram negative organisms, Spirillae and Rickettsia. It acts by interfering with bacterial protein synthesis. Chloramphenicol is widely distributed in body tissues and fluids and enters the cerebrospinal fluid.

Chloramphenicol sodium succinate, free chloramphenicol and metabolites are excreted in the urine.

Pharmacokinetic properties

After intravenous administration of chloramphenicol succinate every 6 hours elimination half-lives were 4.03 hours for chloramphenicol and 2.65 hours for chloramphenicol succinate. After intravenous chloramphenicol sodium succinate, steady state peak concentrations were reached on average 18.0 minutes after cessation of the infusion.

In infants and children aged 3 days to 16 years the apparent half-life was extremely variable ranging from 1.7 to 12.0 hours.

Preclinical safety data

None stated.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.